509 related articles for article (PubMed ID: 16622621)
1. [Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer].
Souchon R; Dunst J; Hartmann KA
Strahlenther Onkol; 2006 Apr; 182(4):202-9. PubMed ID: 16622621
[TBL] [Abstract][Full Text] [Related]
2. Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy.
Gerlach B; Audretsch W; Gogolin F; Königshausen T; Rohn R; Schmitt G; Dimmerling P; Gripp S; Hartmann KA
Strahlenther Onkol; 2003 May; 179(5):306-11. PubMed ID: 12740657
[TBL] [Abstract][Full Text] [Related]
3. Regarding: Valero V, Buzdar AU, Hortobagyi GN. "Locally Advanced Breast Cancer," The Oncologist 1996;1:8-17.
Oliver RT
Oncologist; 1996; 1(4):278-279. PubMed ID: 10388003
[TBL] [Abstract][Full Text] [Related]
4. Primary systemic therapy of breast cancer.
Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
[TBL] [Abstract][Full Text] [Related]
5. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
6. Preoperative (neoadjuvant) systemic treatment of breast cancer.
Kaufmann M; von Minckwitz G; Rody A
Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
[TBL] [Abstract][Full Text] [Related]
7. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
Kaufmann M; von Minckwitz G; Smith R; Valero V; Gianni L; Eiermann W; Howell A; Costa SD; Beuzeboc P; Untch M; Blohmer JU; Sinn HP; Sittek R; Souchon R; Tulusan AH; Volm T; Senn HJ
J Clin Oncol; 2003 Jul; 21(13):2600-8. PubMed ID: 12829681
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
[TBL] [Abstract][Full Text] [Related]
9. Management of locally advanced breast cancer. Mini-review.
Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
[TBL] [Abstract][Full Text] [Related]
12. [Role of induction chemo- and radiotherapy in the treatment of locally advance breast cancer].
Voznyĭ EK; Kharchenko VP; Pan'shin GA; Gurov SN; Dobrovol'skaia NI; Galil-Ogly GA; Khmelevskiĭ EV; Alipchenko LA; Bol'shakova SA
Vopr Onkol; 2000; 46(6):736-40. PubMed ID: 11219950
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
[TBL] [Abstract][Full Text] [Related]
15. The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.
Clouth B; Chandrasekharan S; Inwang R; Smith S; Davidson N; Sauven P
Eur J Surg Oncol; 2007 Oct; 33(8):961-6. PubMed ID: 17215100
[TBL] [Abstract][Full Text] [Related]
16. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the effectiveness of various comprehensive treatments for locally advanced breast cancer].
Kharchenko VP; Khmelevskiĭ EV; Panyshin GA
Vopr Onkol; 1998; 44(4):443-6. PubMed ID: 9807210
[TBL] [Abstract][Full Text] [Related]
18. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G
J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270
[TBL] [Abstract][Full Text] [Related]
19. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
[TBL] [Abstract][Full Text] [Related]
20. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
